Effect of intravenous dexamethasone palmitate compared to dexamethasone on the duration of ropivacaine axillary brachial plexus block

Effect of intravenous dexamethasone palmitate compared to dexamethasone on the duration of ropivacaine axillary brachial plexus block: a randomized controlled trial.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0009618

Enrollment

Registered

2024-07-10

Start date

2024-06-24

Completion date

Unknown

Last updated

2024-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Among patients scheduled for axillary brachial plexus and upper extremity surgery performed under general anesthesia under supervised general anesthesia at our hospital, patients with ASA class

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: * ASA physical status 1-3 * Age: 19-80 years * Patients with brachial plexus block and scheduled upper extremity surgery under supervised general anesthesia

Exclusion criteria

Exclusion criteria: * Informed Consent Refusers * Pregnancy * Any contraindication to axillary brachial plexus block (Any contraindication to axillary BPB) * Pre-existing neuropathy involving the surgical limb (Pre-existing neuropathy involving the surgical limb) * systemic use of corticosteroids for 2 weeks or longer within 6 months of surgery (systemic use of corticosteroids for 2 weeks or longer within 6 months of surgery) * Allergy to any medication included in the study protocol, including ropivacaine. Translated with DeepL.com (free version)

Design outcomes

Primary

Measure	Time frame
sensory block duration ;motor block duration	—

Secondary

Measure	Time frame
Time to first analgesic intake after axillary brachial plexus block;Analgesic consumption 24 and 48 hours after surgery;QoR-15 (Quality of recovery-15);Pain score at 8, 24, and 48 hours after surgery (NRS score);Patient satisfaction (7-point Likert’s scale);Quantity and quality of sleep on the day of surgery (numerical rating scale for sleep); Complications related to postoperative nerve block procedure (general local anesthesia toxicity, paresthesia or nerve damage);Complications due to dexamethasone administration (infection or increased blood sugar)	—

Measure

Time frame

Time to first analgesic intake after axillary brachial plexus block;Analgesic consumption 24 and 48 hours after surgery;QoR-15 (Quality of recovery-15);Pain score at 8, 24, and 48 hours after surgery (NRS score);Patient satisfaction (7-point Likert’s scale);Quantity and quality of sleep on the day of surgery (numerical rating scale for sleep); Complications related to postoperative nerve block procedure (general local anesthesia toxicity, paresthesia or nerve damage);Complications due to dexamethasone administration (infection or increased blood sugar)

—

Countries

Korea, Republic of

Contacts

Public ContactYeon Ju Kim

Asan Medical Center

clever8808@naver.com+82-2-3010-3888

Outcome results